Global Blood Glucose Device Market By Product Type (Blood Glucose Monitors, Glucose Monitoring Strips) And By End-Users/Application (Hospitals, Diagnostics) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the Blood Glucose Device market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on Blood Glucose Device market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of Blood Glucose Device industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the Blood Glucose Device ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Blood Glucose Device market.

The following manufacturers are covered in this report:
  • Abbott Laboratories (U.S.)
  • ARKRAY (Japan)
  • Dexcom (U.S.)
  • F.Hoffmann-La Roche Ltd (Switzerland)
  • Johnson & Johnson (U.S.)
  • Medtronic (U.S.)
  • Nipro Diagnostics (U.S.)
  • Terumo Medical Corporation (U.S.)

The report estimates on the Blood Glucose Device market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global Blood Glucose Device market report consist of all leading industry players, Blood Glucose Device business sections, company profile, revenue supply by Blood Glucose Device industry sections, global Blood Glucose Device market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the Blood Glucose Device market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the Blood Glucose Device market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on Blood Glucose Device market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Blood Glucose Device market.

Report Opportunity: Global Blood Glucose Device Market

This report delivers an analytical examination of the Blood Glucose Device market summarized in broad sections such as
  1. Blood Glucose Device Market Summary
  2. Key Commercial Growths in the Blood Glucose Device Industry
  3. Market Dynamics Affecting the Blood Glucose Device Industry
  4. Important Market Trends and Future Development Scenario of the Blood Glucose Device Market
  5. Blood Glucose Device Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Blood Glucose Device Industry
  7. Positioning of Main Market Players in the Blood Glucose Device Industry
  8. Blood Glucose Device Market Revenue and Forecast, by Application, 2018 - 2028
  9. Blood Glucose Device Market Revenue and Forecast, by End-use, 2018 - 2028
  10. Blood Glucose Device Market Revenue and Forecast, by Geography, 2018 - 2028
Blood Glucose Device Market Segmentation:

The report provides detailed examination of the Blood Glucose Device market on the basis of various segments such as type, application and end-use industry. The Blood Glucose Device market is segmented as follows:

Blood Glucose Device Market, by Type:
  • Blood Glucose Monitors
  • Glucose Monitoring Strips
  • Lancets
Blood Glucose Device Market, by Application:
  • Hospitals
  • Diagnostics
  • Home Settings
  • Others
Geographic Coverage

The report on the Blood Glucose Device market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Blood Glucose Device Market Revenue and Forecast
  • U.S.
  • Canada
Europe Blood Glucose Device Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific Blood Glucose Device Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Blood Glucose Device Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Blood Glucose Device Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Blood Glucose Device Market Snapshot
          2.1.1. Global Blood Glucose Device Market By Type,2019
               2.1.1.1.Blood Glucose Monitors
               2.1.1.2.Glucose Monitoring Strips
               2.1.1.3.Lancets
          2.1.2. Global Blood Glucose Device Market By Application,2019
               2.1.2.1.Hospitals
               2.1.2.2.Diagnostics
               2.1.2.3.Home Settings
               2.1.2.4.Others
          2.1.3. Global Blood Glucose Device Market By End-use,2019
          2.1.4. Global Blood Glucose Device Market By Geography,2019

3. Global Blood Glucose Device Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Blood Glucose Device Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Blood Glucose Device Market Size (US$), By Type, 2018 – 2028

5. Global Blood Glucose Device Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Blood Glucose Device Market Size (US$), By Application, 2018 – 2028

6. Global Blood Glucose Device Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Blood Glucose Device Market Size (US$), By End-use, 2018 – 2028

7. Global Blood Glucose Device Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Blood Glucose Device Market Analysis, 2018 – 2028 
          7.2.1. North America Blood Glucose Device Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Blood Glucose Device Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Blood Glucose Device Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Blood Glucose Device Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Blood Glucose Device Market Analysis, 2018 – 2028 
          7.3.1.  Europe Blood Glucose Device Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Blood Glucose Device Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Blood Glucose Device Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Blood Glucose Device Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Blood Glucose Device Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Blood Glucose Device Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Blood Glucose Device Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Blood Glucose Device Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Blood Glucose Device Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Blood Glucose Device Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Blood Glucose Device Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Blood Glucose Device Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Blood Glucose Device Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Blood Glucose Device Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Blood Glucose Device Market Analysis, 2018 – 2028 
          7.6.1.  MEA Blood Glucose Device Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Blood Glucose Device Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Blood Glucose Device Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Blood Glucose Device Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Blood Glucose Device Providers
        8.4.1 Abbott Laboratories (U.S.)
                8.1.1 Business Description
                8.1.2 Abbott Laboratories (U.S.) Geographic Operations
                8.1.3 Abbott Laboratories (U.S.) Financial Information
                8.1.4 Abbott Laboratories (U.S.) Product Positions/Portfolio
                8.1.5 Abbott Laboratories (U.S.) Key Developments
        8.4.2 ARKRAY (Japan)
                8.2.1 Business Description
                8.2.2 ARKRAY (Japan) Geographic Operations
                8.2.3 ARKRAY (Japan) Financial Information
                8.2.4 ARKRAY (Japan) Product Positions/Portfolio
                8.2.5 ARKRAY (Japan) Key Developments
        8.4.3 Dexcom (U.S.)
                8.3.1 Business Description
                8.3.2 Dexcom (U.S.) Geographic Operations
                8.3.3 Dexcom (U.S.) Financial Information
                8.3.4 Dexcom (U.S.) Product Positions/Portfolio
                8.3.5 Dexcom (U.S.) Key Developments
        8.4.4 F.Hoffmann-La Roche Ltd (Switzerland)
                8.4.1 Business Description
                8.4.2 F.Hoffmann-La Roche Ltd (Switzerland) Geographic Operations
                8.4.3 F.Hoffmann-La Roche Ltd (Switzerland) Financial Information
                8.4.4 F.Hoffmann-La Roche Ltd (Switzerland) Product Positions/Portfolio
                8.4.5 F.Hoffmann-La Roche Ltd (Switzerland) Key Developments
        8.4.5 Johnson & Johnson (U.S.)
                8.5.1 Business Description
                8.5.2 Johnson & Johnson (U.S.) Geographic Operations
                8.5.3 Johnson & Johnson (U.S.) Financial Information
                8.5.4 Johnson & Johnson (U.S.) Product Positions/Portfolio
                8.5.5 Johnson & Johnson (U.S.) Key Developments
        8.4.6 Medtronic (U.S.)
                8.6.1 Business Description
                8.6.2 Medtronic (U.S.) Geographic Operations
                8.6.3 Medtronic (U.S.) Financial Information
                8.6.4 Medtronic (U.S.) Product Positions/Portfolio
                8.6.5 Medtronic (U.S.) Key Developments
        8.4.7 Nipro Diagnostics (U.S.)
                8.7.1 Business Description
                8.7.2 Nipro Diagnostics (U.S.) Geographic Operations
                8.7.3 Nipro Diagnostics (U.S.) Financial Information
                8.7.4 Nipro Diagnostics (U.S.) Product Positions/Portfolio
                8.7.5 Nipro Diagnostics (U.S.) Key Developments
        8.4.8 Terumo Medical Corporation (U.S.)
                8.8.1 Business Description
                8.8.2 Terumo Medical Corporation (U.S.) Geographic Operations
                8.8.3 Terumo Medical Corporation (U.S.) Financial Information
                8.8.4 Terumo Medical Corporation (U.S.) Product Positions/Portfolio
                8.8.5 Terumo Medical Corporation (U.S.) Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Blood Glucose Device Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Blood Glucose Device Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Blood Glucose Device Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Blood Glucose Device Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Blood Glucose Device Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Blood Glucose Device Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Blood Glucose Device Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Blood Glucose Device Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Blood Glucose Device Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Blood Glucose Device Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Blood Glucose Device Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Blood Glucose Device Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Blood Glucose Device Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Blood Glucose Device Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Blood Glucose Device Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Blood Glucose Device Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Blood Glucose Device: Market Segmentation 
FIG. 2 Global Blood Glucose Device Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Blood Glucose Device Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Blood Glucose Device Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Blood Glucose Device Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Blood Glucose Device Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Blood Glucose Device Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Blood Glucose Device Providers, 2019
FIG. 11 Global Blood Glucose Device Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Blood Glucose Device Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Blood Glucose Device Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Blood Glucose Device Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Blood Glucose Device Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Blood Glucose Device Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Blood Glucose Device Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Blood Glucose Device Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Blood Glucose Device market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
2144

1928

OUR CLIENT